New Approaches to Myeloma Treatment: What You Need to Know and What You Need to Tell Your Patients
Source: New Approaches to Myeloma Treatment: What You Need to Know and What You Need to Tell Your Patients

Video Module

In this archived webcast from the CCO management of patients with myeloma live meeting series, Joseph D. Tariman, PhD, ANP-BC, provides expert perspective on ways that nurses can help optimize treatment choices for patients with advanced myeloma through shared decision making.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe specific strategies to engage patients with multiple myeloma and their caregivers in shared decision making to make them an active participant in their care
  • Educate patients with multiple myeloma on the anticipated adverse events of various treatment options so that they will be empowered to participate in treatment decision making
  • Interact with patients with multiple myeloma and caregivers to evaluate resources for continuous education and support as a source of empowerment

Topics covered include:

  • The New Era of Shared Decision Making in Oncology
  • Clinical Updates in Multiple Myeloma
  • Advances in Therapy for Newly Diagnosed and Relapsed/Refractory MM
  • Moving Forward: Implementing SDM in Current Practice
CCO Video Modules contain video commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.
 

Faculty

  • Joseph D. Tariman
    PhD, ANP-BC

Credit Information

  • Release Date:
    December 23, 2016
  • Expiration Date:
    December 22, 2017
  • Registered Nurses:
    1.0 Nursing contact hour

Information on this Educational Activity

Disclosure of Conflicts of Interest

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty

Joseph D. Tariman, PhD, ANP-BC


Assistant Professor
DePaul University
Chicago, Illinois

Joseph D. Tariman, PhD, ANP-BC, has reported that he has no real or apparent financial conflicts to disclose.

 

Staff

Terrence Fagan, 


Associate Managing Editor

Terrence Fagan has no real or apparent conflicts of interest to report.

 

Gordon Kelley, 


Senior Clinical Editor

Gordon Kelley has no real or apparent conflicts of interest to report.

 

Kevin Obholz, PhD


Editorial Director, Hematology/Oncology

Kevin Obholz, PhD, has no real or apparent conflicts of interest to report.

 

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Charles E. Willis, MBA, Director of Continuing Education, Amanda Sewell, MBA, Manager of Continuing Education, Debbie Price, Registration Database Administrator, and Alma Perez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), Clinical Care Options, and activity supporters do not recommend the use of any agent outside of the labeled indications.


The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, Clinical Care Options, and activity supporters. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

 

Target Audience

This activity is intended for oncology nurses and other healthcare providers who provide care for patients with multiple myeloma.


Goal

The goal of this activity is to provide education and tools that help oncology nurses provide optimal care for patients with multiple myeloma within a shared decision making framework.


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe specific strategies to engage patients with multiple myeloma and their caregivers in shared decision making to make them an active participant in their care
  • Educate patients with multiple myeloma on the anticipated adverse events of various treatment options so that they will be empowered to participate in treatment decision making
  • Interact with patients with multiple myeloma and caregivers to evaluate resources for continuous education and support as a source of empowerment
 

Nursing Continuing Education

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

1.0 contact hour may be earned for successful completion of this activity.

 

Commercial Support


This program is supported by educational grants from Amgen, Celgene Corporation, and Novartis Oncology.

 

Program Medium


This program has been made available online.

 

Site Requirements


  • Internet Explorer 7+, Firefox 3+, Safari 3+, or Chrome
  • JavaScript enabled
  • 1024x768+ screen resolution
  • Adobe Flash Player
 

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 23, 2016, through December 22, 2017:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.